US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 2.440
  • -0.060-2.40%
Close May 2 16:00 ET
  • 2.330
  • -0.110-4.51%
Post 17:21 ET
241.31MMarket Cap-3490P/E (TTM)

About AC Immune Company

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Company Profile

SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andrea Pfeifer, PhD
  • Chief Executive Officer and Director
  • --
  • Dr. Nuno Mendonça, M.D.
  • Chief Medical Officer
  • --
  • Piergiorgio Donati
  • Chief Technical Operations Officer
  • --
  • Jean-Fabien Monin
  • Chief Administrative Officer
  • --
  • Christopher Roberts
  • Chief Financial Officer
  • --
  • Howard Donovan
  • Chief Human Resources Officer
  • --
  • Dr. Madiha Derouazi, PhD
  • Chief Scientific Officer
  • --
  • Dr. Gary Waanders, PhD
  • Senior Vice President, Investor Relations and Corporate Communications
  • --
  • Mark Danton
  • Senior Vice President Information Systems and Artificial Intelligence
  • --
  • Dr. Julien Rongere, PhD
  • Senior Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Dr. Bojana Portmann, PhD
  • Vice President, IP and Business Development
  • --
  • Dr. Olivier Sol, M.D.
  • Vice President and Head of Clinical Development
  • --
  • Dr. Douglas E. WilliaPhD
  • Chairman of the Board
  • --
  • Professor Dr. Monika Butler, PhD
  • Vice Chairman of the Board and Director
  • --
  • Monica Shaw
  • Independent Director
  • --
  • Dr. Roy Twyman, M.D.
  • Independent Director
  • --
  • Professor Carl June, M.D.
  • Independent Director
  • --
  • Dr. Werner Lanthaler, PhD
  • Independent Director
  • --
  • Dr. Marie Kosco-Vilbois, PhD
  • Scientific Advisor
  • --
  • Dr. Julian Gray, PhD
  • Clinical Advisor
  • --
  • Alexandre Caratsch
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg